Concord Biotech Limited has announced the approval of the allotment of 10,46,16,204 equity shares of Rs. 1/- each as fully paid-up bonus equity shares. This allotment is in the proportion of 1 (One) equity share for every 1 (One) existing fully paid-up equity share. The record date for this bonus issue was set as Wednesday, November 04, 2026, leading to an increase in the company’s paid-up share capital to Rs. 20,92,32,408/-.
Concord Biotech Approves Substantial Bonus Share Allotment
Concord Biotech Limited has formally approved the allotment of a significant number of bonus equity shares. The decision, made by the Board of Directors through a circular resolution, involves the issuance of 10,46,16,204 equity shares. Each share has a face value of Rs. 1/- and will be issued as fully paid-up.
Bonus Ratio and Record Date
The bonus shares will be distributed in a ratio of 1 (One) bonus equity share for every 1 (One) existing fully paid-up equity share held by eligible shareholders. The company has designated Wednesday, November 04, 2026, as the record date for determining the eligible shareholders entitled to receive these bonus shares. Shareholders listed in the company’s register of members on this date will be eligible.
Impact on Share Capital
Following this substantial allotment, the total paid-up share capital of Concord Biotech Limited will increase. The company’s paid-up share capital now stands at Rs. 20,92,32,408/-, which is now represented by 20,92,32,408 fully paid-up equity shares, each with a face value of Rs. 1/-. This move is expected to enhance the company’s capital base and potentially benefit shareholders.
Source: BSE
